Home > Insider Trading > Filing (0001209191-18-046821)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1660334	Verrica Pharmaceuticals Inc.	VRCA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1494695	B Paul Manning	200 Garrett Street, Suite S Charlottesville VA 22902		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-06-19	200,000	$15.00	7,987,783	No	4	P	Direct
Common Stock	Acquisiton	2018-06-19	100,000	$15.00	1,260,244	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	256,634	Indirect	See Footnote

Footnotes

This represent the total number of shares owned by the Reporting Person including the shares acquired on August 10, 2018.
Consists of 7,754,783 shares of common stock held by Mr. Manning and 233,000 shares of common stock held by Mr. Manning jointly with his spouse.
The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and has sole voting and investment power with respect to the shares held by BKB.
The shares are held directly by PBM Capital Investments, LLC ("PBMCI"). The Reporting Person is President and CEO of PBMCI and has sole voting and investment power with respect to the shares held by PBMCI.